ESMO Guidance for Reporting Oncology real-World evidence (GROW)
Luís Castelo-Branco(European Society for Medical Oncology), Miriam Koopman(Utrecht University), Tereza Dellaporta(Frontier Science Foundation-Hellas), Anna Pellat(Université Paris Cité), Judith M. Bliss(Institute of Cancer Research), Rolf A. Stahel(International Breast Cancer Study Group), George Pentheroudakis(Hellenic Cooperative Oncology Group), Peter S Hall(University of Edinburgh), Jeroen W. G. Derksen(Utrecht University), Henrique Martins(Iscte – Instituto Universitário de Lisboa), Antonios Valachis(Örebro University Hospital), Arsela Prelaj(Fondazione IRCCS Istituto Nazionale dei Tumori), Jakob Nikolas Kather(Heidelberg University), Arndt Vogel(Princess Margaret Cancer Centre), Suzette Delaloge(Institut Gustave Roussy), Urania Dafni(Frontier Science Foundation-Hellas), Rodrigo Dienstmann(Universitat de Vic - Universitat Central de Catalunya), Nuria Ribelles(Instituto de Investigación Biomédica de Málaga), Karijn P.M. Suijkerbuijk(University Medical Center Utrecht), Christopher M. Booth(Queen's University), Rolf H. H. Groenwold(Leiden University Medical Center), Francesco Perrone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Diogo Martins-Branco(Université Libre de Bruxelles)
Cited by 209
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
|JAMA|2003|1.4k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k